U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C66H122N6O38P4S4
Molecular Weight 1859.847
Optical Activity UNSPECIFIED
Defined Stereocenters 19 / 19
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Zerlasiran 5'-modification

SMILES

CO[C@@H]1[C@H](O)[C@@H](COP(O)(=S)OCCCCCCOCC(COCCCOP(O)(=S)OCCCCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)(COCCCOP(O)(=S)OCCCCO[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)COCCCOP(O)(=S)OCCCCO[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4NC(C)=O)O[C@H]1N5C=CC(N)=NC5=O

InChI

InChIKey=ORJSJIGSEZSCDD-JOZDTAFESA-N
InChI=1S/C66H122N6O38P4S4/c1-42(76)68-50-57(83)53(79)45(34-73)108-62(50)96-24-9-12-28-99-111(87,115)103-31-15-21-93-39-66(40-94-22-16-32-104-112(88,116)100-29-13-10-25-97-63-51(69-43(2)77)58(84)54(80)46(35-74)109-63,41-95-23-17-33-105-113(89,117)101-30-14-11-26-98-64-52(70-44(3)78)59(85)55(81)47(36-75)110-64)38-92-20-7-5-6-8-27-102-114(90,118)106-37-48-56(82)60(91-4)61(107-48)72-19-18-49(67)71-65(72)86/h18-19,45-48,50-64,73-75,79-85H,5-17,20-41H2,1-4H3,(H,68,76)(H,69,77)(H,70,78)(H,87,115)(H,88,116)(H,89,117)(H,90,118)(H2,67,71,86)/t45-,46-,47-,48-,50-,51-,52-,53+,54+,55+,56-,57-,58-,59-,60-,61-,62-,63-,64-,66?,111?,112?,113?,114?/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
Zerlasiran 5'-modification
Common Name English
Methylcytidylyl-5′-[O-[21-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-9,9-bis[12-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-7-mercapto-7-oxido-2,6,8-trioxa-7-phosphadodec-1-yl]-16-mercapto-16-oxido-7,11,15,17-tetraoxa-16-phosphahenei
Common Name English
Code System Code Type Description
FDA UNII
VTF9MMJ8CN
Created by admin on Sat Dec 16 19:18:56 GMT 2023 , Edited by admin on Sat Dec 16 19:18:56 GMT 2023
PRIMARY
PUBCHEM
166177242
Created by admin on Sat Dec 16 19:18:56 GMT 2023 , Edited by admin on Sat Dec 16 19:18:56 GMT 2023
PRIMARY